A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)
- Saiama N. Waqar
- , Mary W. Redman
- , Susanne M. Arnold
- , Fred R. Hirsch
- , Philip C. Mack
- , Lawrence H. Schwartz
- , David R. Gandara
- , Thomas E. Stinchcombe
- , Natasha B. Leighl
- , Suresh S. Ramalingam
- , Saloni H. Tanna
- , Ryan S. Raddin
- , Katherine Minichiello
- , Jeffrey D. Bradley
- , Karen Kelly
- , Roy S. Herbst
- , Vassiliki A. Papadimitrakopoulou
Research output: Contribution to journal › Article › peer-review
69
Scopus
citations